Pharma & Healthcare
Global Gastrointestinal Function Regulating Probiotics Market Outlook, In‑Depth Analysis & Forecast to 2031
- Oct 16, 25
- ID: 552154
- Pages: 148
- Figures: 139
- Views: 12
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Gastrointestinal Function Regulating Probiotics market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Probiotics International
Ganeden Biotech
Chr. Hansen
DSM
Yakult
BioGaia
Probi
ProbioFerm
Protexin
Segment by Type
Capsule
Tablets
Powder
Solution or Emulsion
Segment by Application
For Children
For Adults
For the Elderly
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Gastrointestinal Function Regulating Probiotics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Gastrointestinal Function Regulating Probiotics market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Probiotics International
Ganeden Biotech
Chr. Hansen
DSM
Yakult
BioGaia
Probi
ProbioFerm
Protexin
Segment by Type
Capsule
Tablets
Powder
Solution or Emulsion
Segment by Application
For Children
For Adults
For the Elderly
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Gastrointestinal Function Regulating Probiotics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Gastrointestinal Function Regulating Probiotics: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Gastrointestinal Function Regulating Probiotics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Capsule
1.2.3 Tablets
1.2.4 Powder
1.2.5 Solution or Emulsion
1.3 Market Segmentation by Application
1.3.1 Global Gastrointestinal Function Regulating Probiotics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 For Children
1.3.3 For Adults
1.3.4 For the Elderly
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal Function Regulating Probiotics Revenue Estimates and Forecasts 2020-2031
2.2 Global Gastrointestinal Function Regulating Probiotics Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Gastrointestinal Function Regulating Probiotics Sales Estimates and Forecasts 2020-2031
2.4 Global Gastrointestinal Function Regulating Probiotics Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Gastrointestinal Function Regulating Probiotics Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Gastrointestinal Function Regulating Probiotics Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Capsule Market Size by Manufacturers
3.5.2 Tablets Market Size by Manufacturers
3.5.3 Powder Market Size by Manufacturers
3.5.4 Solution or Emulsion Market Size by Manufacturers
3.6 Global Gastrointestinal Function Regulating Probiotics Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Gastrointestinal Function Regulating Probiotics Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Gastrointestinal Function Regulating Probiotics Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Gastrointestinal Function Regulating Probiotics Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Gastrointestinal Function Regulating Probiotics Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Gastrointestinal Function Regulating Probiotics Sales and Revenue by Type (2020-2031)
6.4 North America Gastrointestinal Function Regulating Probiotics Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Gastrointestinal Function Regulating Probiotics Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Gastrointestinal Function Regulating Probiotics Sales and Revenue by Type (2020-2031)
7.4 Europe Gastrointestinal Function Regulating Probiotics Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Gastrointestinal Function Regulating Probiotics Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Gastrointestinal Function Regulating Probiotics Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Gastrointestinal Function Regulating Probiotics Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Gastrointestinal Function Regulating Probiotics Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Gastrointestinal Function Regulating Probiotics Sales and Revenue by Type (2020-2031)
9.4 Central and South America Gastrointestinal Function Regulating Probiotics Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Gastrointestinal Function Regulating Probiotics Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Gastrointestinal Function Regulating Probiotics Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Gastrointestinal Function Regulating Probiotics Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Gastrointestinal Function Regulating Probiotics Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Probiotics International
11.1.1 Probiotics International Corporation Information
11.1.2 Probiotics International Business Overview
11.1.3 Probiotics International Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.1.4 Probiotics International Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Probiotics International Gastrointestinal Function Regulating Probiotics Sales by Product in 2024
11.1.6 Probiotics International Gastrointestinal Function Regulating Probiotics Sales by Application in 2024
11.1.7 Probiotics International Gastrointestinal Function Regulating Probiotics Sales by Geographic Area in 2024
11.1.8 Probiotics International Gastrointestinal Function Regulating Probiotics SWOT Analysis
11.1.9 Probiotics International Recent Developments
11.2 Ganeden Biotech
11.2.1 Ganeden Biotech Corporation Information
11.2.2 Ganeden Biotech Business Overview
11.2.3 Ganeden Biotech Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.2.4 Ganeden Biotech Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Ganeden Biotech Gastrointestinal Function Regulating Probiotics Sales by Product in 2024
11.2.6 Ganeden Biotech Gastrointestinal Function Regulating Probiotics Sales by Application in 2024
11.2.7 Ganeden Biotech Gastrointestinal Function Regulating Probiotics Sales by Geographic Area in 2024
11.2.8 Ganeden Biotech Gastrointestinal Function Regulating Probiotics SWOT Analysis
11.2.9 Ganeden Biotech Recent Developments
11.3 Chr. Hansen
11.3.1 Chr. Hansen Corporation Information
11.3.2 Chr. Hansen Business Overview
11.3.3 Chr. Hansen Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.3.4 Chr. Hansen Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Chr. Hansen Gastrointestinal Function Regulating Probiotics Sales by Product in 2024
11.3.6 Chr. Hansen Gastrointestinal Function Regulating Probiotics Sales by Application in 2024
11.3.7 Chr. Hansen Gastrointestinal Function Regulating Probiotics Sales by Geographic Area in 2024
11.3.8 Chr. Hansen Gastrointestinal Function Regulating Probiotics SWOT Analysis
11.3.9 Chr. Hansen Recent Developments
11.4 DSM
11.4.1 DSM Corporation Information
11.4.2 DSM Business Overview
11.4.3 DSM Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.4.4 DSM Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 DSM Gastrointestinal Function Regulating Probiotics Sales by Product in 2024
11.4.6 DSM Gastrointestinal Function Regulating Probiotics Sales by Application in 2024
11.4.7 DSM Gastrointestinal Function Regulating Probiotics Sales by Geographic Area in 2024
11.4.8 DSM Gastrointestinal Function Regulating Probiotics SWOT Analysis
11.4.9 DSM Recent Developments
11.5 Yakult
11.5.1 Yakult Corporation Information
11.5.2 Yakult Business Overview
11.5.3 Yakult Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.5.4 Yakult Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Yakult Gastrointestinal Function Regulating Probiotics Sales by Product in 2024
11.5.6 Yakult Gastrointestinal Function Regulating Probiotics Sales by Application in 2024
11.5.7 Yakult Gastrointestinal Function Regulating Probiotics Sales by Geographic Area in 2024
11.5.8 Yakult Gastrointestinal Function Regulating Probiotics SWOT Analysis
11.5.9 Yakult Recent Developments
11.6 BioGaia
11.6.1 BioGaia Corporation Information
11.6.2 BioGaia Business Overview
11.6.3 BioGaia Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.6.4 BioGaia Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 BioGaia Recent Developments
11.7 Probi
11.7.1 Probi Corporation Information
11.7.2 Probi Business Overview
11.7.3 Probi Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.7.4 Probi Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Probi Recent Developments
11.8 ProbioFerm
11.8.1 ProbioFerm Corporation Information
11.8.2 ProbioFerm Business Overview
11.8.3 ProbioFerm Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.8.4 ProbioFerm Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 ProbioFerm Recent Developments
11.9 Protexin
11.9.1 Protexin Corporation Information
11.9.2 Protexin Business Overview
11.9.3 Protexin Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.9.4 Protexin Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Protexin Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Gastrointestinal Function Regulating Probiotics Industry Chain
12.2 Gastrointestinal Function Regulating Probiotics Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Gastrointestinal Function Regulating Probiotics Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Gastrointestinal Function Regulating Probiotics Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Gastrointestinal Function Regulating Probiotics Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Gastrointestinal Function Regulating Probiotics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Gastrointestinal Function Regulating Probiotics: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Gastrointestinal Function Regulating Probiotics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Capsule
1.2.3 Tablets
1.2.4 Powder
1.2.5 Solution or Emulsion
1.3 Market Segmentation by Application
1.3.1 Global Gastrointestinal Function Regulating Probiotics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 For Children
1.3.3 For Adults
1.3.4 For the Elderly
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal Function Regulating Probiotics Revenue Estimates and Forecasts 2020-2031
2.2 Global Gastrointestinal Function Regulating Probiotics Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Gastrointestinal Function Regulating Probiotics Sales Estimates and Forecasts 2020-2031
2.4 Global Gastrointestinal Function Regulating Probiotics Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Gastrointestinal Function Regulating Probiotics Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Gastrointestinal Function Regulating Probiotics Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Capsule Market Size by Manufacturers
3.5.2 Tablets Market Size by Manufacturers
3.5.3 Powder Market Size by Manufacturers
3.5.4 Solution or Emulsion Market Size by Manufacturers
3.6 Global Gastrointestinal Function Regulating Probiotics Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Gastrointestinal Function Regulating Probiotics Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Gastrointestinal Function Regulating Probiotics Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Gastrointestinal Function Regulating Probiotics Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Gastrointestinal Function Regulating Probiotics Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Gastrointestinal Function Regulating Probiotics Sales and Revenue by Type (2020-2031)
6.4 North America Gastrointestinal Function Regulating Probiotics Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Gastrointestinal Function Regulating Probiotics Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Gastrointestinal Function Regulating Probiotics Sales and Revenue by Type (2020-2031)
7.4 Europe Gastrointestinal Function Regulating Probiotics Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Gastrointestinal Function Regulating Probiotics Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Gastrointestinal Function Regulating Probiotics Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Gastrointestinal Function Regulating Probiotics Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Gastrointestinal Function Regulating Probiotics Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Gastrointestinal Function Regulating Probiotics Sales and Revenue by Type (2020-2031)
9.4 Central and South America Gastrointestinal Function Regulating Probiotics Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Gastrointestinal Function Regulating Probiotics Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Gastrointestinal Function Regulating Probiotics Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Gastrointestinal Function Regulating Probiotics Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Gastrointestinal Function Regulating Probiotics Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Probiotics International
11.1.1 Probiotics International Corporation Information
11.1.2 Probiotics International Business Overview
11.1.3 Probiotics International Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.1.4 Probiotics International Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Probiotics International Gastrointestinal Function Regulating Probiotics Sales by Product in 2024
11.1.6 Probiotics International Gastrointestinal Function Regulating Probiotics Sales by Application in 2024
11.1.7 Probiotics International Gastrointestinal Function Regulating Probiotics Sales by Geographic Area in 2024
11.1.8 Probiotics International Gastrointestinal Function Regulating Probiotics SWOT Analysis
11.1.9 Probiotics International Recent Developments
11.2 Ganeden Biotech
11.2.1 Ganeden Biotech Corporation Information
11.2.2 Ganeden Biotech Business Overview
11.2.3 Ganeden Biotech Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.2.4 Ganeden Biotech Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Ganeden Biotech Gastrointestinal Function Regulating Probiotics Sales by Product in 2024
11.2.6 Ganeden Biotech Gastrointestinal Function Regulating Probiotics Sales by Application in 2024
11.2.7 Ganeden Biotech Gastrointestinal Function Regulating Probiotics Sales by Geographic Area in 2024
11.2.8 Ganeden Biotech Gastrointestinal Function Regulating Probiotics SWOT Analysis
11.2.9 Ganeden Biotech Recent Developments
11.3 Chr. Hansen
11.3.1 Chr. Hansen Corporation Information
11.3.2 Chr. Hansen Business Overview
11.3.3 Chr. Hansen Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.3.4 Chr. Hansen Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Chr. Hansen Gastrointestinal Function Regulating Probiotics Sales by Product in 2024
11.3.6 Chr. Hansen Gastrointestinal Function Regulating Probiotics Sales by Application in 2024
11.3.7 Chr. Hansen Gastrointestinal Function Regulating Probiotics Sales by Geographic Area in 2024
11.3.8 Chr. Hansen Gastrointestinal Function Regulating Probiotics SWOT Analysis
11.3.9 Chr. Hansen Recent Developments
11.4 DSM
11.4.1 DSM Corporation Information
11.4.2 DSM Business Overview
11.4.3 DSM Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.4.4 DSM Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 DSM Gastrointestinal Function Regulating Probiotics Sales by Product in 2024
11.4.6 DSM Gastrointestinal Function Regulating Probiotics Sales by Application in 2024
11.4.7 DSM Gastrointestinal Function Regulating Probiotics Sales by Geographic Area in 2024
11.4.8 DSM Gastrointestinal Function Regulating Probiotics SWOT Analysis
11.4.9 DSM Recent Developments
11.5 Yakult
11.5.1 Yakult Corporation Information
11.5.2 Yakult Business Overview
11.5.3 Yakult Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.5.4 Yakult Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Yakult Gastrointestinal Function Regulating Probiotics Sales by Product in 2024
11.5.6 Yakult Gastrointestinal Function Regulating Probiotics Sales by Application in 2024
11.5.7 Yakult Gastrointestinal Function Regulating Probiotics Sales by Geographic Area in 2024
11.5.8 Yakult Gastrointestinal Function Regulating Probiotics SWOT Analysis
11.5.9 Yakult Recent Developments
11.6 BioGaia
11.6.1 BioGaia Corporation Information
11.6.2 BioGaia Business Overview
11.6.3 BioGaia Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.6.4 BioGaia Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 BioGaia Recent Developments
11.7 Probi
11.7.1 Probi Corporation Information
11.7.2 Probi Business Overview
11.7.3 Probi Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.7.4 Probi Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Probi Recent Developments
11.8 ProbioFerm
11.8.1 ProbioFerm Corporation Information
11.8.2 ProbioFerm Business Overview
11.8.3 ProbioFerm Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.8.4 ProbioFerm Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 ProbioFerm Recent Developments
11.9 Protexin
11.9.1 Protexin Corporation Information
11.9.2 Protexin Business Overview
11.9.3 Protexin Gastrointestinal Function Regulating Probiotics Product Models, Descriptions and Specifications
11.9.4 Protexin Gastrointestinal Function Regulating Probiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Protexin Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Gastrointestinal Function Regulating Probiotics Industry Chain
12.2 Gastrointestinal Function Regulating Probiotics Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Gastrointestinal Function Regulating Probiotics Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Gastrointestinal Function Regulating Probiotics Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Gastrointestinal Function Regulating Probiotics Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Gastrointestinal Function Regulating Probiotics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Gastrointestinal Function Regulating Probiotics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Gastrointestinal Function Regulating Probiotics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Gastrointestinal Function Regulating Probiotics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Gastrointestinal Function Regulating Probiotics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Gastrointestinal Function Regulating Probiotics Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Gastrointestinal Function Regulating Probiotics Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Dose)
Table 7. Global Gastrointestinal Function Regulating Probiotics Sales by Region (2020-2025) & (K Dose)
Table 8. Global Gastrointestinal Function Regulating Probiotics Sales by Region (2026-2031) & (K Dose)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Gastrointestinal Function Regulating Probiotics Sales by Manufacturers (2020-2025) & (K Dose)
Table 11. Global Gastrointestinal Function Regulating Probiotics Sales Share by Manufacturers (2020-2025)
Table 12. Global Gastrointestinal Function Regulating Probiotics Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Gastrointestinal Function Regulating Probiotics Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Gastrointestinal Function Regulating Probiotics by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Function Regulating Probiotics as of 2024)
Table 16. Global Gastrointestinal Function Regulating Probiotics Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Gastrointestinal Function Regulating Probiotics Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Dose)
Table 18. Key Manufacturers Gastrointestinal Function Regulating Probiotics Manufacturing Base and Headquarters
Table 19. Global Gastrointestinal Function Regulating Probiotics Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Gastrointestinal Function Regulating Probiotics Sales by Type (2020-2025) & (K Dose)
Table 23. Global Gastrointestinal Function Regulating Probiotics Sales by Type (2026-2031) & (K Dose)
Table 24. Global Gastrointestinal Function Regulating Probiotics Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Gastrointestinal Function Regulating Probiotics Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Gastrointestinal Function Regulating Probiotics ASP by Type (2020-2031) & (US$/Dose)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Gastrointestinal Function Regulating Probiotics Sales by Application (2020-2025) & (K Dose)
Table 29. Global Gastrointestinal Function Regulating Probiotics Sales by Application (2026-2031) & (K Dose)
Table 30. Gastrointestinal Function Regulating Probiotics High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Gastrointestinal Function Regulating Probiotics Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Gastrointestinal Function Regulating Probiotics Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Gastrointestinal Function Regulating Probiotics ASP by Application (2020-2031) & (US$/Dose)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Gastrointestinal Function Regulating Probiotics Growth Accelerators and Market Barriers
Table 37. North America Gastrointestinal Function Regulating Probiotics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Gastrointestinal Function Regulating Probiotics Sales (K Dose) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Gastrointestinal Function Regulating Probiotics Growth Accelerators and Market Barriers
Table 40. Europe Gastrointestinal Function Regulating Probiotics Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Gastrointestinal Function Regulating Probiotics Sales (K Dose) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Gastrointestinal Function Regulating Probiotics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Gastrointestinal Function Regulating Probiotics Sales (K Dose) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Gastrointestinal Function Regulating Probiotics Growth Accelerators and Market Barriers
Table 45. Southeast Asia Gastrointestinal Function Regulating Probiotics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Gastrointestinal Function Regulating Probiotics Investment Opportunities and Key Challenges
Table 47. Central and South America Gastrointestinal Function Regulating Probiotics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Gastrointestinal Function Regulating Probiotics Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Gastrointestinal Function Regulating Probiotics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Probiotics International Corporation Information
Table 51. Probiotics International Description and Major Businesses
Table 52. Probiotics International Product Models, Descriptions and Specifications
Table 53. Probiotics International Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 54. Probiotics International Sales Value Proportion by Product in 2024
Table 55. Probiotics International Sales Value Proportion by Application in 2024
Table 56. Probiotics International Sales Value Proportion by Geographic Area in 2024
Table 57. Probiotics International Gastrointestinal Function Regulating Probiotics SWOT Analysis
Table 58. Probiotics International Recent Developments
Table 59. Ganeden Biotech Corporation Information
Table 60. Ganeden Biotech Description and Major Businesses
Table 61. Ganeden Biotech Product Models, Descriptions and Specifications
Table 62. Ganeden Biotech Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 63. Ganeden Biotech Sales Value Proportion by Product in 2024
Table 64. Ganeden Biotech Sales Value Proportion by Application in 2024
Table 65. Ganeden Biotech Sales Value Proportion by Geographic Area in 2024
Table 66. Ganeden Biotech Gastrointestinal Function Regulating Probiotics SWOT Analysis
Table 67. Ganeden Biotech Recent Developments
Table 68. Chr. Hansen Corporation Information
Table 69. Chr. Hansen Description and Major Businesses
Table 70. Chr. Hansen Product Models, Descriptions and Specifications
Table 71. Chr. Hansen Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 72. Chr. Hansen Sales Value Proportion by Product in 2024
Table 73. Chr. Hansen Sales Value Proportion by Application in 2024
Table 74. Chr. Hansen Sales Value Proportion by Geographic Area in 2024
Table 75. Chr. Hansen Gastrointestinal Function Regulating Probiotics SWOT Analysis
Table 76. Chr. Hansen Recent Developments
Table 77. DSM Corporation Information
Table 78. DSM Description and Major Businesses
Table 79. DSM Product Models, Descriptions and Specifications
Table 80. DSM Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 81. DSM Sales Value Proportion by Product in 2024
Table 82. DSM Sales Value Proportion by Application in 2024
Table 83. DSM Sales Value Proportion by Geographic Area in 2024
Table 84. DSM Gastrointestinal Function Regulating Probiotics SWOT Analysis
Table 85. DSM Recent Developments
Table 86. Yakult Corporation Information
Table 87. Yakult Description and Major Businesses
Table 88. Yakult Product Models, Descriptions and Specifications
Table 89. Yakult Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 90. Yakult Sales Value Proportion by Product in 2024
Table 91. Yakult Sales Value Proportion by Application in 2024
Table 92. Yakult Sales Value Proportion by Geographic Area in 2024
Table 93. Yakult Gastrointestinal Function Regulating Probiotics SWOT Analysis
Table 94. Yakult Recent Developments
Table 95. BioGaia Corporation Information
Table 96. BioGaia Description and Major Businesses
Table 97. BioGaia Product Models, Descriptions and Specifications
Table 98. BioGaia Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 99. BioGaia Recent Developments
Table 100. Probi Corporation Information
Table 101. Probi Description and Major Businesses
Table 102. Probi Product Models, Descriptions and Specifications
Table 103. Probi Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 104. Probi Recent Developments
Table 105. ProbioFerm Corporation Information
Table 106. ProbioFerm Description and Major Businesses
Table 107. ProbioFerm Product Models, Descriptions and Specifications
Table 108. ProbioFerm Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 109. ProbioFerm Recent Developments
Table 110. Protexin Corporation Information
Table 111. Protexin Description and Major Businesses
Table 112. Protexin Product Models, Descriptions and Specifications
Table 113. Protexin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 114. Protexin Recent Developments
Table 115. Key Raw Materials Distribution
Table 116. Raw Materials Key Suppliers
Table 117. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 118. Milestones in Production Technology Evolution
Table 119. Distributors List
Table 120. Market Trends and Market Evolution
Table 121. Market Drivers and Opportunities
Table 122. Market Challenges, Risks, and Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastrointestinal Function Regulating Probiotics Product Picture
Figure 2. Global Gastrointestinal Function Regulating Probiotics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Capsule Product Picture
Figure 4. Tablets Product Picture
Figure 5. Powder Product Picture
Figure 6. Solution or Emulsion Product Picture
Figure 7. Global Gastrointestinal Function Regulating Probiotics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. For Children
Figure 9. For Adults
Figure 10. For the Elderly
Figure 11. Gastrointestinal Function Regulating Probiotics Report Years Considered
Figure 12. Global Gastrointestinal Function Regulating Probiotics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 14. Global Gastrointestinal Function Regulating Probiotics Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Gastrointestinal Function Regulating Probiotics Revenue Market Share by Region (2020-2031)
Figure 16. Global Gastrointestinal Function Regulating Probiotics Sales (2020-2031) & (K Dose)
Figure 17. Global Gastrointestinal Function Regulating Probiotics Sales (CAGR) by Region (2020-2031) (K Dose)
Figure 18. Global Gastrointestinal Function Regulating Probiotics Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Gastrointestinal Function Regulating Probiotics Sales Volume Market Share in 2024
Figure 20. Global Gastrointestinal Function Regulating Probiotics Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Capsule Revenue Market Share by Manufacturer in 2024
Figure 23. Tablets Revenue Market Share by Manufacturer in 2024
Figure 24. Powder Revenue Market Share by Manufacturer in 2024
Figure 25. Solution or Emulsion Revenue Market Share by Manufacturer in 2024
Figure 26. Global Gastrointestinal Function Regulating Probiotics Sales Market Share by Type (2020-2031)
Figure 27. Global Gastrointestinal Function Regulating Probiotics Revenue Market Share by Type (2020-2031)
Figure 28. Global Gastrointestinal Function Regulating Probiotics Sales Market Share by Application (2020-2031)
Figure 29. Global Gastrointestinal Function Regulating Probiotics Revenue Market Share by Application (2020-2031)
Figure 30. North America Gastrointestinal Function Regulating Probiotics Sales YoY (2020-2031) & (K Dose)
Figure 31. North America Gastrointestinal Function Regulating Probiotics Revenue YoY (2020-2031) & (US$ Million)
Figure 32. North America Top 5 Manufacturers Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) in 2024
Figure 33. North America Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Type (2020- 2031)
Figure 34. North America Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 35. North America Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Application (2020-2031)
Figure 36. North America Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 37. US Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 38. Canada Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 40. Europe Gastrointestinal Function Regulating Probiotics Sales YoY (2020-2031) & (K Dose)
Figure 41. Europe Gastrointestinal Function Regulating Probiotics Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Europe Top 5 Manufacturers Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) in 2024
Figure 43. Europe Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Type (2020-2031)
Figure 44. Europe Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Type (2020-2031)
Figure 45. Europe Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Application (2020-2031)
Figure 46. Europe Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. Germany Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 48. France Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 49. U.K. Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 50. Italy Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 51. Russia Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Gastrointestinal Function Regulating Probiotics Sales YoY (2020-2031) & (K Dose)
Figure 53. Asia-Pacific Gastrointestinal Function Regulating Probiotics Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Top 8 Manufacturers Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) in 2024
Figure 55. Asia-Pacific Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Type (2020- 2031)
Figure 56. Asia-Pacific Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 57. Asia-Pacific Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Application (2020-2031)
Figure 58. Asia-Pacific Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Indonesia Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 60. Japan Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 61. South Korea Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 62. China Taiwan Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 63. India Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 64. Central and South America Gastrointestinal Function Regulating Probiotics Sales YoY (2020-2031) & (K Dose)
Figure 65. Central and South America Gastrointestinal Function Regulating Probiotics Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Manufacturers Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) in 2024
Figure 67. Central and South America Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Type (2021-2031)
Figure 68. Central and South America Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Type (2020-2031)
Figure 69. Central and South America Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Application (2020-2031)
Figure 70. Central and South America Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Brazil Gastrointestinal Function Regulating Probiotics Revenue (2020-2025) & (US$ Million)
Figure 72. Argentina Gastrointestinal Function Regulating Probiotics Revenue (2020-2025) & (US$ Million)
Figure 73. Middle East, and Africa Gastrointestinal Function Regulating Probiotics Sales YoY (2020-2031) & (K Dose)
Figure 74. Middle East and Africa Gastrointestinal Function Regulating Probiotics Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Middle East and Africa Top 5 Manufacturers Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) in 2024
Figure 76. Middle East and Africa Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Type (2021-2031)
Figure 77. South America Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Middle East and Africa Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Application (2020-2031)
Figure 79. Middle East and Africa Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. GCC Countries Gastrointestinal Function Regulating Probiotics Revenue (2020-2025) & (US$ Million)
Figure 81. Turkey Gastrointestinal Function Regulating Probiotics Revenue (2020-2025) & (US$ Million)
Figure 82. Egypt Gastrointestinal Function Regulating Probiotics Revenue (2020-2025) & (US$ Million)
Figure 83. South Africa Gastrointestinal Function Regulating Probiotics Revenue (2020-2025) & (US$ Million)
Figure 84. Gastrointestinal Function Regulating Probiotics Industry Chain Mapping
Figure 85. Regional Gastrointestinal Function Regulating Probiotics Manufacturing Base Distribution (%)
Figure 86. Global Gastrointestinal Function Regulating Probiotics Production Market Share by Region (2020-2031)
Figure 87. Gastrointestinal Function Regulating Probiotics Production Process
Figure 88. Regional Gastrointestinal Function Regulating Probiotics Production Cost Structure
Figure 89. Channels of Distribution (Direct Vs Distribution)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Table 1. Global Gastrointestinal Function Regulating Probiotics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Gastrointestinal Function Regulating Probiotics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Gastrointestinal Function Regulating Probiotics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Gastrointestinal Function Regulating Probiotics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Gastrointestinal Function Regulating Probiotics Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Gastrointestinal Function Regulating Probiotics Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Dose)
Table 7. Global Gastrointestinal Function Regulating Probiotics Sales by Region (2020-2025) & (K Dose)
Table 8. Global Gastrointestinal Function Regulating Probiotics Sales by Region (2026-2031) & (K Dose)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Gastrointestinal Function Regulating Probiotics Sales by Manufacturers (2020-2025) & (K Dose)
Table 11. Global Gastrointestinal Function Regulating Probiotics Sales Share by Manufacturers (2020-2025)
Table 12. Global Gastrointestinal Function Regulating Probiotics Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Gastrointestinal Function Regulating Probiotics Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Gastrointestinal Function Regulating Probiotics by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Function Regulating Probiotics as of 2024)
Table 16. Global Gastrointestinal Function Regulating Probiotics Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Gastrointestinal Function Regulating Probiotics Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Dose)
Table 18. Key Manufacturers Gastrointestinal Function Regulating Probiotics Manufacturing Base and Headquarters
Table 19. Global Gastrointestinal Function Regulating Probiotics Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Gastrointestinal Function Regulating Probiotics Sales by Type (2020-2025) & (K Dose)
Table 23. Global Gastrointestinal Function Regulating Probiotics Sales by Type (2026-2031) & (K Dose)
Table 24. Global Gastrointestinal Function Regulating Probiotics Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Gastrointestinal Function Regulating Probiotics Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Gastrointestinal Function Regulating Probiotics ASP by Type (2020-2031) & (US$/Dose)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Gastrointestinal Function Regulating Probiotics Sales by Application (2020-2025) & (K Dose)
Table 29. Global Gastrointestinal Function Regulating Probiotics Sales by Application (2026-2031) & (K Dose)
Table 30. Gastrointestinal Function Regulating Probiotics High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Gastrointestinal Function Regulating Probiotics Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Gastrointestinal Function Regulating Probiotics Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Gastrointestinal Function Regulating Probiotics ASP by Application (2020-2031) & (US$/Dose)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Gastrointestinal Function Regulating Probiotics Growth Accelerators and Market Barriers
Table 37. North America Gastrointestinal Function Regulating Probiotics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Gastrointestinal Function Regulating Probiotics Sales (K Dose) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Gastrointestinal Function Regulating Probiotics Growth Accelerators and Market Barriers
Table 40. Europe Gastrointestinal Function Regulating Probiotics Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Gastrointestinal Function Regulating Probiotics Sales (K Dose) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Gastrointestinal Function Regulating Probiotics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Gastrointestinal Function Regulating Probiotics Sales (K Dose) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Gastrointestinal Function Regulating Probiotics Growth Accelerators and Market Barriers
Table 45. Southeast Asia Gastrointestinal Function Regulating Probiotics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Gastrointestinal Function Regulating Probiotics Investment Opportunities and Key Challenges
Table 47. Central and South America Gastrointestinal Function Regulating Probiotics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Gastrointestinal Function Regulating Probiotics Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Gastrointestinal Function Regulating Probiotics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Probiotics International Corporation Information
Table 51. Probiotics International Description and Major Businesses
Table 52. Probiotics International Product Models, Descriptions and Specifications
Table 53. Probiotics International Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 54. Probiotics International Sales Value Proportion by Product in 2024
Table 55. Probiotics International Sales Value Proportion by Application in 2024
Table 56. Probiotics International Sales Value Proportion by Geographic Area in 2024
Table 57. Probiotics International Gastrointestinal Function Regulating Probiotics SWOT Analysis
Table 58. Probiotics International Recent Developments
Table 59. Ganeden Biotech Corporation Information
Table 60. Ganeden Biotech Description and Major Businesses
Table 61. Ganeden Biotech Product Models, Descriptions and Specifications
Table 62. Ganeden Biotech Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 63. Ganeden Biotech Sales Value Proportion by Product in 2024
Table 64. Ganeden Biotech Sales Value Proportion by Application in 2024
Table 65. Ganeden Biotech Sales Value Proportion by Geographic Area in 2024
Table 66. Ganeden Biotech Gastrointestinal Function Regulating Probiotics SWOT Analysis
Table 67. Ganeden Biotech Recent Developments
Table 68. Chr. Hansen Corporation Information
Table 69. Chr. Hansen Description and Major Businesses
Table 70. Chr. Hansen Product Models, Descriptions and Specifications
Table 71. Chr. Hansen Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 72. Chr. Hansen Sales Value Proportion by Product in 2024
Table 73. Chr. Hansen Sales Value Proportion by Application in 2024
Table 74. Chr. Hansen Sales Value Proportion by Geographic Area in 2024
Table 75. Chr. Hansen Gastrointestinal Function Regulating Probiotics SWOT Analysis
Table 76. Chr. Hansen Recent Developments
Table 77. DSM Corporation Information
Table 78. DSM Description and Major Businesses
Table 79. DSM Product Models, Descriptions and Specifications
Table 80. DSM Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 81. DSM Sales Value Proportion by Product in 2024
Table 82. DSM Sales Value Proportion by Application in 2024
Table 83. DSM Sales Value Proportion by Geographic Area in 2024
Table 84. DSM Gastrointestinal Function Regulating Probiotics SWOT Analysis
Table 85. DSM Recent Developments
Table 86. Yakult Corporation Information
Table 87. Yakult Description and Major Businesses
Table 88. Yakult Product Models, Descriptions and Specifications
Table 89. Yakult Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 90. Yakult Sales Value Proportion by Product in 2024
Table 91. Yakult Sales Value Proportion by Application in 2024
Table 92. Yakult Sales Value Proportion by Geographic Area in 2024
Table 93. Yakult Gastrointestinal Function Regulating Probiotics SWOT Analysis
Table 94. Yakult Recent Developments
Table 95. BioGaia Corporation Information
Table 96. BioGaia Description and Major Businesses
Table 97. BioGaia Product Models, Descriptions and Specifications
Table 98. BioGaia Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 99. BioGaia Recent Developments
Table 100. Probi Corporation Information
Table 101. Probi Description and Major Businesses
Table 102. Probi Product Models, Descriptions and Specifications
Table 103. Probi Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 104. Probi Recent Developments
Table 105. ProbioFerm Corporation Information
Table 106. ProbioFerm Description and Major Businesses
Table 107. ProbioFerm Product Models, Descriptions and Specifications
Table 108. ProbioFerm Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 109. ProbioFerm Recent Developments
Table 110. Protexin Corporation Information
Table 111. Protexin Description and Major Businesses
Table 112. Protexin Product Models, Descriptions and Specifications
Table 113. Protexin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 114. Protexin Recent Developments
Table 115. Key Raw Materials Distribution
Table 116. Raw Materials Key Suppliers
Table 117. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 118. Milestones in Production Technology Evolution
Table 119. Distributors List
Table 120. Market Trends and Market Evolution
Table 121. Market Drivers and Opportunities
Table 122. Market Challenges, Risks, and Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastrointestinal Function Regulating Probiotics Product Picture
Figure 2. Global Gastrointestinal Function Regulating Probiotics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Capsule Product Picture
Figure 4. Tablets Product Picture
Figure 5. Powder Product Picture
Figure 6. Solution or Emulsion Product Picture
Figure 7. Global Gastrointestinal Function Regulating Probiotics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. For Children
Figure 9. For Adults
Figure 10. For the Elderly
Figure 11. Gastrointestinal Function Regulating Probiotics Report Years Considered
Figure 12. Global Gastrointestinal Function Regulating Probiotics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 14. Global Gastrointestinal Function Regulating Probiotics Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Gastrointestinal Function Regulating Probiotics Revenue Market Share by Region (2020-2031)
Figure 16. Global Gastrointestinal Function Regulating Probiotics Sales (2020-2031) & (K Dose)
Figure 17. Global Gastrointestinal Function Regulating Probiotics Sales (CAGR) by Region (2020-2031) (K Dose)
Figure 18. Global Gastrointestinal Function Regulating Probiotics Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Gastrointestinal Function Regulating Probiotics Sales Volume Market Share in 2024
Figure 20. Global Gastrointestinal Function Regulating Probiotics Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Capsule Revenue Market Share by Manufacturer in 2024
Figure 23. Tablets Revenue Market Share by Manufacturer in 2024
Figure 24. Powder Revenue Market Share by Manufacturer in 2024
Figure 25. Solution or Emulsion Revenue Market Share by Manufacturer in 2024
Figure 26. Global Gastrointestinal Function Regulating Probiotics Sales Market Share by Type (2020-2031)
Figure 27. Global Gastrointestinal Function Regulating Probiotics Revenue Market Share by Type (2020-2031)
Figure 28. Global Gastrointestinal Function Regulating Probiotics Sales Market Share by Application (2020-2031)
Figure 29. Global Gastrointestinal Function Regulating Probiotics Revenue Market Share by Application (2020-2031)
Figure 30. North America Gastrointestinal Function Regulating Probiotics Sales YoY (2020-2031) & (K Dose)
Figure 31. North America Gastrointestinal Function Regulating Probiotics Revenue YoY (2020-2031) & (US$ Million)
Figure 32. North America Top 5 Manufacturers Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) in 2024
Figure 33. North America Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Type (2020- 2031)
Figure 34. North America Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 35. North America Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Application (2020-2031)
Figure 36. North America Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 37. US Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 38. Canada Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 40. Europe Gastrointestinal Function Regulating Probiotics Sales YoY (2020-2031) & (K Dose)
Figure 41. Europe Gastrointestinal Function Regulating Probiotics Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Europe Top 5 Manufacturers Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) in 2024
Figure 43. Europe Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Type (2020-2031)
Figure 44. Europe Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Type (2020-2031)
Figure 45. Europe Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Application (2020-2031)
Figure 46. Europe Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. Germany Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 48. France Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 49. U.K. Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 50. Italy Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 51. Russia Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Gastrointestinal Function Regulating Probiotics Sales YoY (2020-2031) & (K Dose)
Figure 53. Asia-Pacific Gastrointestinal Function Regulating Probiotics Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Top 8 Manufacturers Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) in 2024
Figure 55. Asia-Pacific Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Type (2020- 2031)
Figure 56. Asia-Pacific Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 57. Asia-Pacific Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Application (2020-2031)
Figure 58. Asia-Pacific Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Indonesia Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 60. Japan Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 61. South Korea Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 62. China Taiwan Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 63. India Gastrointestinal Function Regulating Probiotics Revenue (2020-2031) & (US$ Million)
Figure 64. Central and South America Gastrointestinal Function Regulating Probiotics Sales YoY (2020-2031) & (K Dose)
Figure 65. Central and South America Gastrointestinal Function Regulating Probiotics Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Manufacturers Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) in 2024
Figure 67. Central and South America Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Type (2021-2031)
Figure 68. Central and South America Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Type (2020-2031)
Figure 69. Central and South America Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Application (2020-2031)
Figure 70. Central and South America Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Brazil Gastrointestinal Function Regulating Probiotics Revenue (2020-2025) & (US$ Million)
Figure 72. Argentina Gastrointestinal Function Regulating Probiotics Revenue (2020-2025) & (US$ Million)
Figure 73. Middle East, and Africa Gastrointestinal Function Regulating Probiotics Sales YoY (2020-2031) & (K Dose)
Figure 74. Middle East and Africa Gastrointestinal Function Regulating Probiotics Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Middle East and Africa Top 5 Manufacturers Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) in 2024
Figure 76. Middle East and Africa Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Type (2021-2031)
Figure 77. South America Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Middle East and Africa Gastrointestinal Function Regulating Probiotics Sales Volume (K Dose) by Application (2020-2031)
Figure 79. Middle East and Africa Gastrointestinal Function Regulating Probiotics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. GCC Countries Gastrointestinal Function Regulating Probiotics Revenue (2020-2025) & (US$ Million)
Figure 81. Turkey Gastrointestinal Function Regulating Probiotics Revenue (2020-2025) & (US$ Million)
Figure 82. Egypt Gastrointestinal Function Regulating Probiotics Revenue (2020-2025) & (US$ Million)
Figure 83. South Africa Gastrointestinal Function Regulating Probiotics Revenue (2020-2025) & (US$ Million)
Figure 84. Gastrointestinal Function Regulating Probiotics Industry Chain Mapping
Figure 85. Regional Gastrointestinal Function Regulating Probiotics Manufacturing Base Distribution (%)
Figure 86. Global Gastrointestinal Function Regulating Probiotics Production Market Share by Region (2020-2031)
Figure 87. Gastrointestinal Function Regulating Probiotics Production Process
Figure 88. Regional Gastrointestinal Function Regulating Probiotics Production Cost Structure
Figure 89. Channels of Distribution (Direct Vs Distribution)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232